Post your job infront of 100,000+ qualified LP's and GP's.
Investment Analyst Jobs in Chicago, IL
Recently Filled Jobs
Sponsored
Texas PSF - Investment Operations Analyst Job lp
Texas Permanent School Fund
Austin, TX ,United States of America
Investment Analyst - Real Estate Job lp
Alaska Permanent Fund Corporation
Juneau or Anchorage, AK ,United States of America
Investment Analyst - Real Estate Job lp
Alaska Permanent Fund Corporation
Juneau, AK; Anchorage, AK ,United States of America
Investment Risk Analyst Job
Columbia Threadneedle Investments
Boston, MA; Minneapolis, MN ,United States of America
Sr Investment Risk Analyst Job gp
Franklin Templeton Investments
New York, NY ,United States of America
Investment Analyst - Public Equity Job lp
North Carolina Retirement Systems
Wake County, NC ,United States of America
Investment Analyst Job lp
Johns Hopkins University Endowment
Baltimore, MD ,United States of America
Similar Jobs
Firms you might be interested in
Georgia Southwestern State University
Endowment
News
Deepcell Raises $20M To Identify Cells With Computer Vision
Deepcell, a startup developing technologies to identify cells using computer vision, has raised $20 million in venture capital. : Learn how to accelerate customer service, optimize costs, and improve self-service in a digital-first world. Deepcell, a Silicon Valley startup spun out of Stanford University in 2017 with a novel way to identify cells using AI, today raised $20 million. The company says the funds will be put toward bolstering development of its technology and enabling it to drive a “hypothesis-free” … Full investment news article
Relevent to this post: Brunei Investment Agency
Stanford Management Company,
Abcellera Biologics Sets Terms Of Ipo, Which Could Value The Company At Up To $4.5B
AbCellera Biologics Inc. said Monday that terms of its initial public offering have been set, which could value the artificial intelligence (AI)-powered drug discovery company at up to $4.52 billion. The Vancouver-based company, which is working with Eli Lilly & Co. on a COVID-19 therapy, said it is offering 23 million shares in the IPO, which is expected to price between $14 and $17 a share, which means the company could raise as much as $391 million. The company expects … Full investment news article
Relevent to this post: University of Nebraska Foundation
SVG,